Prevalence of Vitreous Hemorrhage Following Coronary Revascularization in Patients With Diabetic Retinopathy

被引:3
|
作者
Kawashima, Dai [1 ]
Ohno, Takayuki [5 ]
Kinoshita, Osamu
Motomura, Noboru
Kiyosue, Arihiro [2 ]
Fujita, Hideo [2 ]
Ando, Jiro [2 ]
Ohtomo, Kazuyoshi [3 ]
Shigeeda, Takashi [3 ]
Kato, Satoshi [3 ]
Kadowaki, Takashi [4 ]
Nagai, Ryozo [2 ]
Takamoto, Shinichi [5 ]
Ono, Minoru
机构
[1] Univ Tokyo, Dept Cardiothorac Surg, Bunkyo Ku, Tokyo 1138655, Japan
[2] Univ Tokyo, Dept Cardiol, Tokyo 1138655, Japan
[3] Univ Tokyo, Dept Ophthalmol, Tokyo 1138655, Japan
[4] Univ Tokyo, Dept Endocrinol & Metab, Tokyo 1138655, Japan
[5] Mitsui Mem Hosp, Dept Cardiovasc Surg, Tokyo 101, Japan
关键词
Coronary artery bypass surgery; Coronary revascularization; Diabetic retinopathy; Drug-eluting stent implantation; Vitreous hemorrhage; DUAL ANTIPLATELET THERAPY; PREMATURE DISCONTINUATION; HEART-ASSOCIATION; AMERICAN-COLLEGE; MORTALITY; MELLITUS; DISEASE;
D O I
10.1253/circj.CJ-10-0404
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: In patients with diabetic retinopathy (DR), vitreous hemorrhage (VH) is a common complication that threatens visual acuity and hence, quality of life. A considerable number of DR patients at risk of VH require coronary revascularization, but little is known about the prevalence of VH after coronary revascularization. Methods and Results: This study investigated 151 patients with DR who were followed up by ophthalmologists between April 2004 and September 2008, and underwent coronary revascularization (coronary artery bypass surgery n=36 or drug-eluting stent implantation n=115). At the time of coronary revascularization 56 had non-proliferative DR (NPDR) and 95 had proliferative DR (PDR). During an average follow-up of 531 days after revascularization, VH occurred in 24 (15.9%) patients, 18 (11.9%) of whom experienced VH within 6 months of the procedure. In VH patients, PDR rather than NPDR predominated as the background to VH (21 vs. 3, respectively). The 1-year prevalence of VH was higher in patients with PDR than in those with NPDR (22.0% vs. 1.9%, P=0.0055). Conclusions: VH is not a rare complication following coronary revascularization among patients with DR, especially in those with PDR. Thus, in terms of maintaining quality of life, VH after coronary revascularization needs further attention in these patients. (Circ J 2011; 75: 329-335)
引用
收藏
页码:329 / 335
页数:7
相关论文
共 50 条
  • [41] VITREOUS FLUOROPHOTOMETRY IN DIABETIC-PATIENTS WITH NO OR MINIMAL RETINOPATHY
    BORDAT, B
    GUIRGIS, IR
    MANDERSCHEID, JC
    JOURNAL FRANCAIS D OPHTALMOLOGIE, 1990, 13 (6-7): : 343 - 347
  • [42] The impact of early vitrectomy for dense vitreous hemorrhage without a history of diabetic retinopathy
    Hayashida, Mayuka
    Miki, Akiko
    Imai, Hisanori
    Azumi, Atsushi
    Nakamura, Makoto
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2018, 59 (09)
  • [43] VITREOUS FLUOROPHOTOMETRY IN PATIENTS WITH NO OR MINIMAL DIABETIC-RETINOPATHY
    CHAHAL, P
    FALLON, TJ
    JENNINGS, SJ
    CHOWIENCZYK, PJ
    KOHNER, EM
    DIABETES CARE, 1986, 9 (02) : 134 - 139
  • [44] Intervitreal Bevacizumab (Avastin) in Treatment of Vitreous Hemorrhage due to Proliferative Diabetic Retinopathy
    Bukhari, Attaullah Shah
    Shah, Aijaz Ahmed
    Siddiqui, Shahid Jamal
    JOURNAL OF THE LIAQUAT UNIVERSITY OF MEDICAL AND HEALTH SCIENCES, 2018, 17 (02): : 76 - 79
  • [45] Intravitreal Bevacizumab for Postoperative Vitreous Hemorrhage after Vitrectomy for Proliferative Diabetic Retinopathy
    Walia, Harpreet
    Rothman, Richard J.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2014, 55 (13)
  • [46] Insulin in the vitreous humor of patients with proliferative diabetic retinopathy
    Sahajpal, Nikhil Shri
    Jain, Subheet
    Vig, Vipan
    Singh, Preetam
    Singh, Rajbir
    Singh, Harshinder
    Singh, Kanwardeep
    Goel, Rajesh
    Yasuda, Janice
    Wright, Dara
    Chaubey, Alka
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2018, 59 (09)
  • [47] Complement Activation in the Vitreous of Patients With Proliferative Diabetic Retinopathy
    Mandava, Nikhil
    Tirado-Gonzalez, Vanessa
    Geiger, Matthew D.
    Patnaik, Jennifer L.
    Frazer-Abel, Ashley
    Lynch, Anne M.
    Mandava, Naresh
    Palestine, Alan G.
    Holers, V. Michael
    Wagner, Brandie D.
    Sanchez-Santos, Idaira
    Meizner, Daniela
    Quiroz-Mercado, Hugo
    Smith, Jesse M.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2020, 61 (11)
  • [48] Vitreous Expression and Processing of Chromogranins in Patients With Diabetic Retinopathy
    Fournier, I. F., Jr.
    Metz-Boutigue, M. -H., Sr.
    Saleh, M.
    Bourcier, T.
    Speeg-Schatz, C.
    Gaucher, D.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2010, 51 (13)
  • [49] The cost-effectiveness of early vitrectomy for the treatment of vitreous hemorrhage in diabetic retinopathy
    Sharma, Sanjay
    Hollands, Hussein
    Brown, Gary C.
    Brown, Melissa M.
    Shah, Gaurav K.
    Sharma, Susan M.
    CURRENT OPINION IN OPHTHALMOLOGY, 2001, 12 (03) : 230 - 234
  • [50] Intravitreal bevacizumab treatment for retinal neovascularization and vitreous hemorrhage in proliferative diabetic retinopathy
    El-Batarny, Ashraf M.
    CLINICAL OPHTHALMOLOGY, 2007, 1 (02): : 149 - 155